About Myriad Genetics (MYGN)
Myriad Genetics, Inc. is a molecular diagnostic company. The Company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. The Company operates through two segments: diagnostics and other. The diagnostic... Read more
- USD19.85
- USD20.09
- USD19.40
- USD24.21
- -3.90%
- 753M
- 820.17k
- 636.01k
- 1.6B
- 13.82
- -9.60%
- 662.80%
Stock News
3 hours ago
Here's how much money you'd have lost if you invested $1,000 in Peloton when it went public
CNBC
3 hours ago
SiriusXM to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference
Yahoo
3 hours ago
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo
3 hours ago
Skittles is giving away a 1-year stay in an NYC micro-apartment that usually rents for $3,500/month: Take a look inside
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
